找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: HDL Deficiency and Atherosclerosis; G. Assmann Book 1995 Kluwer Academic Publishers 1995 Lipoprotein.atherosclerosis.cardiovascular.corona

[復(fù)制鏈接]
樓主: 宣告無效
21#
發(fā)表于 2025-3-25 03:52:23 | 只看該作者
22#
發(fā)表于 2025-3-25 09:33:50 | 只看該作者
Connection between cholesterol efflux and atherosclerosis, The two major subclasses include particles that contain both apoA-I and apoA-II (termed LpA-I, A-II) and those that contain apoA-I but not apoA-II (termed LpA-I). Apo-specific particles can be isolated by use of immunoaffinity columns with anti-apoA-I or anti-apoA-II antibody..
23#
發(fā)表于 2025-3-25 14:06:19 | 只看該作者
https://doi.org/10.1057/9781137295866 possesses arginine. The apoE2 isoform, associated with type III hyperlipoproteinaemia., differs from apoE3 only at residue 158, where it possesses cysteine. Apolipoproteins E3 and E4 bind normally to the low density lipoprotein (LDL) receptor, whereas apoE2 does not.
24#
發(fā)表于 2025-3-25 15:50:58 | 只看該作者
25#
發(fā)表于 2025-3-25 23:18:23 | 只看該作者
Book 1995on of massive scientific research, continuous transfer of the results to medical practice, community actions and population aware- ness. The death rate from coronary heart disease in the United States rose 20% from 1950 to 1963, when a dramatic and steady downward inflection began, arriving today at
26#
發(fā)表于 2025-3-26 01:16:32 | 只看該作者
HDLC as a therapeutic target in coronary disease: current concepts and future directions,support the concepts that HDL-related measures are as important as LDL-related ones in predicting vascular events. Furthermore, pharmacological or genetic modification of certain plasma HDL subfractions appears to hold promise for clinical benefits that are comparable to, or perhaps exceed, those of LDLC reduction.
27#
發(fā)表于 2025-3-26 05:08:55 | 只看該作者
28#
發(fā)表于 2025-3-26 09:51:21 | 只看該作者
HDL Deficiency and Atherosclerosis978-94-011-6585-3Series ISSN 0166-9842
29#
發(fā)表于 2025-3-26 13:04:37 | 只看該作者
30#
發(fā)表于 2025-3-26 17:31:39 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-12 09:04
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
石楼县| 黑山县| 玉山县| 封丘县| 金平| 新乡市| 黄浦区| 东丰县| 永登县| 康马县| 富宁县| 化州市| 永州市| 乃东县| 布拖县| 仙游县| 浮山县| 遵义市| 新泰市| 巴彦县| 贡嘎县| 天津市| 会宁县| 关岭| 雷波县| 麻阳| 佳木斯市| 黑水县| 仲巴县| 岐山县| 扎赉特旗| 鹤山市| 攀枝花市| 聂拉木县| 陵川县| 新河县| 台北县| 香河县| 临江市| 特克斯县| 石狮市|